Imported vs. Domestic: The fight to protect Gulf seafood
Mississippi lawmakers are considering House Bill 602 and Senate Bill 2014, both designed to ensure consumers know whether ...
BioSpace6d
FDA Tacks Boxed Warning on Teva’s Copaxone, Other MS Drugs
The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since ...
Keeping MS under control: New treatments finally bring hope to Floridians living with multiple sclerosis
Susie Wyss used to inject herself daily with a medication for multiple sclerosis. “The injection hurt. It caused welts, ...
Managed Healthcare Executive7d
FDA Adds Boxed Warning to MS Drug Copaxone
Regulatory officials have identified 82 cases worldwide from the FDA Adverse Event Reporting System of anaphylaxis associated ...
The American Journal of Managed Care6d
FDA Warns of Severe Allergic Reactions With Certain Multiple Sclerosis Drugs
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
pharmaphorum21h
First Tysabri biosimilar cleared by FDA for MS
The FDA said the biosimilar, called Tyruko, has been approved to treat adults with relapsing forms of MS and active secondary progressive MS, as well as for certain patients with Crohn's disease ...
SCOTUSblog6d
Menthol vapes and forum shopping, FDA tobacco control comes before justices
The Supreme Court will hear oral arguments on Tuesday in a clash over whether a North Carolina-based company can challenge the Food and Drug Administration’s denial of its application to market ...